In F9 cancer cells, incubation with recombinant SELENOV was associated with significantly increased mRNA levels of several pro-apoptotic genes (BAX, PUMA, CASP-3) and decreased mRNA levels of two anti-apoptotic BCL-2 family genes (BCL-xL and BCL-2). Here, BCL2L1 is linked to cancer.